Skip to main content
OpenTrials

Clinical trial condition

Metastatic Head-and-neck Squamous-cell Carcinoma

Explore clinical trials studying Metastatic Head-and-neck Squamous-cell Carcinoma. Study availability and eligibility vary by location and protocol.

8 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Head-and-neck Squamous-cell Carcinoma trial results

Recruiting

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

NCT06064877

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +14 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Yale School of Medicine - Smilow Cancer Hospital New Haven, Connecticut, United States
View all 112 locations
View Trial Details
Active, Not Recruiting

An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors

NCT04305795

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +10 more
Locations
  • University of Miami Hospital and Clinics Miami, Florida, United States
  • University of Kentucky Lexington, Kentucky, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Providence Medical Center Portland, Oregon, United States
View Trial Details

Related conditions